Theravance Biopharma
TBPH
TBPH
90 hedge funds and large institutions have $297M invested in Theravance Biopharma in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
+1
Holders Change %
+1.12%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
39
Reduced
18
Closed
12
Calls
$77K
Puts
$261K
Net Calls
-$184K
Net Calls Change
-$250K
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$12.7M |
| 2 |
BB
2
BB Biotech
Schaffhausen,
Switzerland
|
$4.68M |
| 3 |
3
Renaissance Technologies
New York
|
$3.44M |
| 4 |
CC
4
Clearline Capital
New York
|
$6.35M |
| 5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$3.14M |
